Formal Synthesis of Perhydrohistrionicotoxin
J . Org. Chem., Vol. 64, No. 15, 1999 5491
was rinsed with THF (5 mL) into a solution of nitrodiacetate
7 (3.45 g 10.0 mmol) in THF (45 mL) in a 100-mL Schlenk
tube equipped with a magnetic stir bar and a coldfinger
condenser. The solution was purged with hydrogen, heated to
just below reflux temperature (60 °C), and vigorously stirred
overnight (14 h) under a hydrogen atmosphere (balloon, 1 atm).
The mixture was filtered, concentrated, and reconstituted in
pyridine (15 mL) and acetic anhydride (15 mL). The solution
was refluxed (1 h), and the solvent was removed under
vacuum. Crystallization of the residual solid from warm
EtOAc/hexanes afforded 3.24 g (91%) of 8 as colorless needles
identical in all respects to that obtained by aluminum amal-
gam. The use of EtOAc as the reduction solvent instead of THF
led to similar results.
3.6, 12.9, 2H), 1.31 (m, 1H); 13C NMR (125 MHz, CDCl3) δ
176.8, 75.0, 64.3 (C6), 31.2, 29.0, 19.9, 19.2, 19.1; 1H NMR (500
MHz, CD3OD) δ 3.35 (dd, J ) 4.1, 11.4, 2H), 2.20 (t, J ) 6.3,
2H), 1.85 (sxt, J ) 5.7, 2H), 1.79 (m 2H), 1.73 (dq, J ) 2.7,
13.1, 2H), 1.70 (dp, J ) 3.1, 13.2, 2H), 1.42 (qd, J ) 3.5, 12.8,
2H), 1.31 (qt, J ) 3.0, 13.1, 1H); 13C NMR (125 MHz, CD3OD)
δ 177.9, 76.3, 65.1, 32.1, 31.0, 21.1, 20.3, 20.2; MS (ES+) 222.1
(M + Na); MS (ES-) 198.3 (M - H).
m eso-(6r ,7R ,11S )-7,11-D ia c e t o x y -1-a za s p ir o [5,5]-
u n d eca n -2-on e (2). To a solution of spirolactam diol 11 (9.5
mg, 0.041 mmol) in dry CH2Cl2 (0.50 mL) was added 4-(dim-
ethylamino)pyridine (15.4 mg, 0.12 mmol) followed by acetyl
chloride (8.0 µL, 0.11 mmol) by syringe. The solution was
stirred (20 min) and directly flash chromatographed to afford
2 (10.0 mg, 77%) as a white solid: mp 128-130 °C; Rf ) 0.60
(4:1 EtOAc/MeOH); IR (pellet) ν 1744, 1671; 1H NMR (500
MHz, CDCl3) δ 5.57 (br s, 1H), 4.61 (dd, J ) 4.0, 10.6, 2H),
2.25 (t, J ) 6.4, 2H), 2.01 (s, 6H), 1.93 (m, 2H), 1.85 (m, 4H),
1.73 (m, 1H), 1.48 (m, 2H), 1.43 (m, 1H); 13C NMR (125 MHz,
CDCl3) δ 173.9, 169.9, 76.4, 60.8, 31.3, 27.0, 21.5, 21.0, 19.3,
18.9; MS (ES+) 305.9 (M + Na). Anal. Calcd for C14H21NO5:
C, 59.35, H, 7.47, N, 4.94. Found: C, 59.32, H, 7.36, N, 5.03.
(-)-(6S,7S,11R)-7-Acetoxy-11-h yd r oxy-1-a za sp ir o[5,5]-
u n d eca n -2-on e (12). To a suspension of spirolactam diacetate
2 (105.5 mg, 0.37 mmol) in 0.27 M phosphate buffer (5 mL,
pH ) 7) was added pig liver esterase (1.0 mL, 2530 U),
resulting in a pH of 7.5. The resulting suspension was stirred
at room temperature (14 days) with periodic (24-48 h)
readjustment of pH to 7.5 using 1 N KOH. When the reaction
was judged complete by TLC analysis (performed by direct
spotting of the aqueous suspension, followed by removal of
water from the TLC plate under vacuum and development),
the mixture was saturated with solid NaCl and adjusted to
pH 5 with 1.2 N HCl. The solution was then filtered slowly
through glass wool. Ethyl acetate (10 × 5 mL) was used to
sequentially wash the filter cake and extract the filtrate. The
combined washings/extracts were dried over sodium sulfate
and concentrated under vacuum to a white solid. The residue
was flash chromatographed on silica gel (10 × 100 mm, packed
with EtOAc, and eluted with EtOAc/MeOH [10:0/9:1/4:1, 50
m eso-(E)-(1r ,2R,6S))-1-Aceta m id o-2,6-d ia cetoxycyclo-
h exa n e-2-bu ten oic Acid , Eth yl Ester (9). Amide 8 (200 mg,
0.51 mmol) was placed in a test tube (25 × 100 mm). Glacial
acetic acid (4.0 mL) and water (1.0 mL) were added. The
solution was sonolyzed (power level 2) at ambient temperature
(1 h). The solution containing the intermediate aldehyde was
concentrated under vacuum and redissolved in CH2Cl2 (4.0
mL). Ethoxycarbonylmethyltriphenylphosphonium bromide
(443 mg, 1.03 mmol) was added, followed by triethylamine
(0.22 mL, 1.58 mmol). The solution was stirred at room
temperature (14 h), concentrated to an oil, and flash chro-
matographed on silica gel (9:1 EtOAc/hexanes) to afford 9 (144
mg, 70%) as an amorphous solid: Rf ) 0.48 (EtOAc); IR (pellet)
1
ν 1742, 1685; H NMR (500 MHz, CDCl3) δ 7.06 (dt, J ) 7.6,
15.5, 1H), 5.88 (d, J ) 15.7, 1H), 5.39 (dd, J ) 4.2, 10.4, 2H),
5.38 (br s, 1H), 4.17 (q, J ) 7.2, 2H), 2.97 (dd, J ) 1.0, 15.6,
2H), 2.03 (s, 6H), 1.85 (s, 3H), 1.82 (m, 2H), 1.76 (dp, J ) 4.1,
13.2, 1H), 1.57 (ad, J ) 4.2, 12.5, 2H), 1.48 (qt, J ) 4.2, 12.3,
1H), 1.26 (t, J ) 7.2, 3H); 13C NMR (125 MHz, CDCl3) δ 170.3,
169.9, 166.17, 144.9, 123.47, 73.49, 62.7, 60.3, 29.9, 27.1, 24.6,
21.0, 18.9, 14.2; MS (ES+) 392.4 (M + Na); MS (ES-) 368.4 (M
- H). Anal. Calcd for C18H27NO7: C, 58.52, H, 7.37, N, 3.79.
Found: C, 58.48, H, 7.36, N, 3.67.
m eso-(1r ,2R,6S)-1-Acet a m id o-2,6-d ia cet oxycycloh ex-
a n ebu ta n oic Acid , Eth yl Ester (10). To a solution of
unsaturated ester 9 (60 mg, 0.15 mmol) in methanol (5.0 mL)
was added 10% palladium on activated charcoal (6.0 mg) under
hydrogen (1 atm). The resulting black suspension was stirred
at room temperature (18 h) and filtered through a fritted glas
funnel packed with Celite (1.0 cm). The filtrate was concen-
trated to afford the saturated ester 10 (57.5 mg, 96%) as an
off-white solid. Recrystallization afforded colorless needles: mp
25
mL each]) to afford 78.1 mg (87%) of 12: mp 165-166 °C; [R]D
-15.0 (c ) 1.04, CHCl3) after crystallization; 93% ee as
determined by integration of the 19F signals of the correspond-
ing (S)-(+)-MTPA ester, major 4.92, minor 4.42 (relative to 3%
TFA in CDCl3) [equally good results could be obtained by
integration of the CHO MTPA proton resonance (major 4.83,
minor 4.91)]; Rf ) 0.07 (EtOAc), 0.37, (EtOAc/MeOH, 4:1); IR
1
116-118 °C; Rf ) 0.43 (EtOAc); IR (pellet) ν 1735, 1684; H
1
NMR (500 MHz, CDCl3) δ 5.86 (br s, 1H), 5.47 (dd, J ) 3.7,
10.0, 2H), 4.13 (q, J ) 7.2, 2H), 2.33 (t, J ) 6.9, 2H), 2.01 (s,
6H), 1.95 (m, 2H), 1.89 (s, 3H), 1.80 (m, 2H), 1.73 (m, 2H),
1.53 (m, 2H), 1.47 (m, 1H), 1.25 (t, J ) 7.2, 3H); 13C NMR (125
MHz, CDCl3) δ 174.1, 170.1, 73.3, 62.1, 60.4, 34.3, 26.9, 26.8,
24.4, 21.1, 18.9, 18.6, 14.2; MS (ES+) 394.3 (M + Na); MS (ES-)
370.4 (M - H). Anal. Calcd for C18H29NO7: C, 58.21, H. 7.87,
N. 3.77. Found: C, 58.46, H, 7.94, N, 3.72.
(film) ν 3317, 1742; H NMR (500 MHz, CDCl3) δ 6.33 (br s,
1H), 4.66 (dd, J ) 4.4, 11.6, 1H), 3.79 (br s, 1H), 3.45 (dt, J )
3.0, 10.9, 1H), 2.23 (t, J ) 6.9, 2H), 2.02 (s, 3H), 1.93 (m, 1H),
1.83 (m, 5H), 1.71 (m, 1H), 1.48 (qd, J ) 4.4, 12.9, 1H), 1.42
(pd, J ) 2.0, 13.2, 1H), 1.36 (qt, J ) 3.7, 13.2, 1H); 13C NMR
(125 MHz, CDCl3) δ 175.4, 170.3, 76.8, 75.3, 62.8, 31.3, 28.8,
27.3, 21.2, 20.2, 19.6, 19.1; MS (ES+) 264.1 (M + Na); MS (ES-)
240.3 (M - H). Anal. Calcd for C12H19NO4‚1/4H2O: C, 58.64;
H, 8.00; N, 5.70. Found: C, 58.96; H, 8.18; N, 5.75.
m eso-(6r ,7R,11S)-2-Oxo-1-a za sp ir o[5,5]u n d eca n -7,11-
d iol (11). Crude saturated ester 10 (17.9 mg, 0.045 mmol) was
suspended in 1.2 N HCl (2.0 mL), refluxed (48 h), and
concentrated under vacuum to afford the crude intermediate
aminocyclohexylbutanoic acid, which was used directly for the
next step but was identified from its NMR spectra: 1H NMR
(500 MHz, D2O) δ 3.47 (dd, J ) 4.5, 12, 2H), 2.37 (t, J ) 5,
2H), 1.7-1.5 (m, 8H), 1.40 (qd, J ) 5, 12, 2H), 1.19 (qt, J ) 4,
13, 1H); 13C NMR (125 MHz, D2O, unreferenced) δ 180.5, 77.6,
66.3, 36.6, 31.4, 26.7, 21.9, 21.3. The crude acid was reconsti-
tuted in pyridine (1.0 mL). 4-(Dimethylamino)pyridine (18.7
mg, 0.15 mmol) and dicyclohexylcarbodiimide (30 mg, 0.15
mmol) were added, and the solution was stirred at room
temperature (24 h). The solution was concentrated under
vacuum and flash chromatographed (2:1 EtOAc/MeOH) to
afford 11 (9.5 mg, 95%, 91% from 10) as a white solid: mp
124-126 °C; Rf ) 0.22 (4:1 EtOAc/MeOH); IR (pellet) ν 3337,
1644; 1H NMR (500 MHz, CDCl3) δ 7.55 (br s, 1H), 3.73 (br s,
2H), 3.39 (dd, J ) 4.0, 11.5, 2H), 2.19 (t, J ) 5.9, 2H), 1.85 (m,
2H), 1.80 (m, 2H), 1.72 (m, 2H), 1.66 (m, 2H), 1.42 (qd, J )
(-)-(6R ,7R ,11S )-11-Ac e t o x y -7-m e t h y lo x a ly lo x y -1-
a za sp ir o[5,5]u n d eca n -2-on e (13). To a solution of monoac-
etate 12 (20 mg, 0.08 mmol) in dry dichloromethane (5 mL)
was added 4-(dimethylamino)pyridine (16.1 mg, 0.13 mmol),
followed by addition of methyloxalyl chloride (12 µL, 0.13
mmol) by syringe. The resulting pale yellow solution was
stirred at room temperature followed by addition of EtOAc (5
mL) and concentration to 0.5 mL. The residual oil was flash
chromatographed on silica gel (10 × 100 mm) with EtOAc to
25
afford (24.0 mg, 87%) of 13 as an amorphous white solid: [R]D
-22.5 (c ) 0.32, CHCl3); Rf ) 0.52 (EtOAc/MeOH, 4:1); IR
1
(neat) ν 1762, 1743; H NMR (500 MHz, CDCl3) δ 5.71 (br s,
1H, NH), 4.74 (dd, J ) 4.4, 11.3, 1H), 4.68 (dd, J ) 4.2, 10.9,
1H), 3.86 (s, 3H), 2.31 (ddd, J ) 4.6, 7.2, 17.1, 1H), 2.21 (ddd,
J ) 6.5, 8.6, 17.1, 1H), 2.02 (s, 3H), 1.96 (m, 3H), 1.80 (m,
3H), 1.59 (qd, J ) 4.4, 13.0, 1H), 1.48 (pd, J ) 3.7, 12.7, 1H),
1.48 (qt, J ) 3.9, 13.0, 1H); 13C NMR (125 MHz, CDCl3) δ 173.9,
170.0, 157.5, 156.4, 79.6, 76.0, 60.8, 53.7, 31.2, 26.8, 26.7, 21.7,
21.0, 19.1, 18.6; MS (ES+) 350.4 (M + Na). Anal. Calcd for